Cargando…

Allogeneic Mesenchymal Stem Cells Ameliorate Aging Frailty: A Phase II Randomized, Double-Blind, Placebo-Controlled Clinical Trial

BACKGROUND: Aging frailty, characterized by decreased physical and immunological functioning, is associated with stem cell depletion. Human allogeneic mesenchymal stem cells (allo-hMSCs) exert immunomodulatory effects and promote tissue repair. METHODS: This is a randomized, double-blinded, dose-fin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tompkins, Bryon A, DiFede, Darcy L, Khan, Aisha, Landin, Ana Marie, Schulman, Ivonne Hernandez, Pujol, Marietsy V, Heldman, Alan W, Miki, Roberto, Goldschmidt-Clermont, Pascal J, Goldstein, Bradley J, Mushtaq, Muzammil, Levis-Dusseau, Silvina, Byrnes, John J, Lowery, Maureen, Natsumeda, Makoto, Delgado, Cindy, Saltzman, Russell, Vidro-Casiano, Mayra, Da Fonseca, Moisaniel, Golpanian, Samuel, Premer, Courtney, Medina, Audrey, Valasaki, Krystalenia, Florea, Victoria, Anderson, Erica, El-Khorazaty, Jill, Mendizabal, Adam, Green, Geoff, Oliva, Anthony A, Hare, Joshua M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2017
Materias:	The Journal of Gerontology: Translational Articles: Stem Cell Transplantation for Frailty
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5861900/ https://www.ncbi.nlm.nih.gov/pubmed/28977399 http://dx.doi.org/10.1093/gerona/glx137

Ejemplares similares

Allogeneic Human Mesenchymal Stem Cell Infusions for Aging Frailty
por: Golpanian, Samuel, et al.
Publicado: (2017)

Genetic determinants of responsiveness to mesenchymal stem cell injections in non-ischemic dilated cardiomyopathy
por: Rieger, Angela C., et al.
Publicado: (2019)

Rationale and design of the allogeneiC human mesenchymal stem cells (hMSC) in patients with aging fRAilTy via intravenoUS delivery (CRATUS) study: A phase I/II, randomized, blinded and placebo controlled trial to evaluate the safety and potential efficacy of allogeneic human mesenchymal stem cell infusion in patients with aging frailty
por: Golpanian, Samuel, et al.
Publicado: (2016)

Understanding variation in disease risk: the elusive concept of frailty
por: Aalen, Odd O, et al.
Publicado: (2015)

Authors’ response: Understanding variation in disease risk
por: Aalen, Odd O, et al.
Publicado: (2015)

Effect of an exercise rehabilitation program on physical function over 1 year in chronic kidney disease: an observational study
por: Hargrove, Nicholas, et al.
Publicado: (2019)

Frailty is independently associated with worse health-related quality of life in chronic kidney disease: a secondary analysis of the Frailty Assessment in Chronic Kidney Disease study
por: Nixon, Andrew C, et al.
Publicado: (2019)

The effect of frailty on the 24‐hour blood pressure pattern in the very elderly
por: Blauth, Fernando Gioppo, et al.
Publicado: (2021)

Predictive Abilities of the Frailty Phenotype and the Swiss Frailty Network and Repository Frailty Index for Non-Home Discharge and Functional Decline in Hospitalized Geriatric Patients
por: Stuck, Anna K., et al.
Publicado: (2022)

The association between patterns of physical activity and sedentary time with frailty in relation to cardiovascular disease
por: Kehler, Dustin Scott, et al.
Publicado: (2019)

The biology of frailty in humans and animals: Understanding frailty and promoting translation
por: Bisset, Elise S., et al.
Publicado: (2019)

Combating frailty and sarcopenia in aging populations: Switching to a more positive paradigm
por: Woo, Jean
Publicado: (2019)

Associations between a laboratory frailty index and adverse health outcomes across age and sex
por: Blodgett, Joanna M., et al.
Publicado: (2019)

Frailty and aging medicine
por: Rockwood, Kenneth
Publicado: (2019)

Feasibility of Virtual Assessment of Physical Frailty in Solid Organ Transplant Recipients: A Single Center, Observational Study
por: de Paula Ferreira, Manoela, et al.
Publicado: (2022)

Allogeneic Cell Combination Therapy Ameliorates Chronic Kidney Disease-Induced Heart Failure with Preserved Ejection Fraction
por: Rieger, Angela C, et al.
Publicado: (2022)

Concise Review: Review and Perspective of Cell Dosage and Routes of Administration From Preclinical and Clinical Studies of Stem Cell Therapy for Heart Disease
por: Golpanian, Samuel, et al.
Publicado: (2016)

The Interdisciplinary Stem Cell Institute’s Use of Food and Drug Administration-Expanded Access Guidelines to Provide Experimental Cell Therapy to Patients With Rare Serious Diseases
por: Khan, Aisha, et al.
Publicado: (2021)

Allogeneic Mesenchymal Stem Cells Restore Endothelial Function in Heart Failure by Stimulating Endothelial Progenitor Cells
por: Premer, Courtney, et al.
Publicado: (2015)

Heart Transplant in Older Adults
por: Rushakoff, Joshua A., et al.
Publicado: (2022)

Association between ambulatory blood pressure variability and frailty among older hypertensive patients
por: Zhu, Yingqian, et al.
Publicado: (2020)

Frailty in liver transplantation: A comprehensive review
por: Liapakis, AnnMarie, et al.
Publicado: (2021)

Comparison of Mesenchymal Stem Cell Efficacy in Ischemic Versus Nonischemic Dilated Cardiomyopathy
por: Tompkins, Bryon A., et al.
Publicado: (2018)

Demographic representation in clinical trials for cell-based therapy
por: Saltzman, Russell G., et al.
Publicado: (2021)

Cognitive Function in Liver Transplantation
por: Albhaisi, Somaya A. M., et al.
Publicado: (2020)

Implication of frailty and disability prevention measures during the COVID‐19 pandemic
por: Yamada, Minoru, et al.
Publicado: (2021)

Implications of frailty interventions from Korean frailty and aging cohort study
por: Won, Chang Won
Publicado: (2021)

Outcome of older adults at risk of frailty
por: Gunasekaran, Venugopalan, et al.
Publicado: (2021)

Review of frailty measurement of older people: Evaluation of the conceptualization, included domains, psychometric properties, and applicability
por: Huang, Emma Yun‐zhi, et al.
Publicado: (2021)

10‐year frailty trajectory is associated with Alzheimer’s dementia after considering neuropathological burden
por: Wallace, Lindsay M. K., et al.
Publicado: (2021)

Prevalence and factors contributing to primary sarcopenia in relatively healthy older Indians attending the outpatient department in a tertiary care hospital: A cross‐sectional study
por: Rahman, Rishal, et al.
Publicado: (2021)

Leukocyte telomere dynamics in the elderly
por: Steenstrup, Troels, et al.
Publicado: (2013)

The Effect of Gender on Mesenchymal Stem Cell (MSC) Efficacy in Neonatal Hyperoxia-Induced Lung Injury
por: Sammour, Ibrahim, et al.
Publicado: (2016)

A novel cardiomyogenic role for Isl1(+) neural crest cells in the inflow tract
por: Hatzistergos, Konstantinos E., et al.
Publicado: (2020)

Mesenchymal Stem Cell Secretion of SDF-1α Modulates Endothelial Function in Dilated Cardiomyopathy
por: Premer, Courtney, et al.
Publicado: (2019)

Rethinking Endothelial Dysfunction as a Crucial Target in Fighting Heart Failure
por: Premer, Courtney, et al.
Publicado: (2019)

Reply to Bennett and Levine
por: Galizia, Gianluigi, et al.
Publicado: (2022)

Usefulness of the tilt table test: A “geriatric” point of view
por: Galizia, Gianluigi, et al.
Publicado: (2022)

Could COVID-19 Induced Endothelial Dysfunction Explain New Onset Peyronie's Disease?
por: Rainer, Q., et al.
Publicado: (2022)

Effects of Transendocardial Stem Cell Injection on Ventricular Proarrhythmia in Patients with Ischemic Cardiomyopathy: Results from the POSEIDON and TAC‐HFT Trials
por: Ramireddy, Archana, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_njt9j3c79df5anm1ja4mv54d2e